“EMA’s safety committee (PRAC) has concluded today that unusual blood clots with low blood platelets should be listed as very rare side effects of Vaxzevria (formerly COVID-19 Vaccine AstraZeneca),” the message said.
It is stated that blood clots might appear two weeks after the vaccination.
The EMA noted that medical aid is urgently needed if a patient feels the following symptoms after the AstraZeneca vaccine use:
- shortness of breath
- chest pain
- swelling in your leg
- persistent abdominal (belly) pain
- neurological symptoms, including severe and persistent headaches or blurred vision
- tiny blood spots under the skin beyond the site of injection.
The research shows that blood clots after the AstraZeneca vaccine occur in veins in the brain and the abdomen and in arteries, together with low levels of blood platelets and sometimes bleeding. The European regulator underlined that the advances of the vaccine continue to surpass the risks.
On April 6, the EMA representative confirmed there is a connection between the AstraZeneca vaccine against coronavirus and the development of blood clots in the patients' bodies.
The first messages about side effects after vaccination with AstraZeneca (Vaxzevria) appeared in early March. Austria was the first to state it suspends the vaccination with the use of this drug. Later, more than 20 countries did the same.